Cardiawave
PrivateLast Round
Crowdfunding
Jun 30, 2026
Est. Valuation
$27.22M
Total Funding Raised
$26.01M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Cardiawave is a medical devices company that has developed Valvosoft®, a non-invasive focused ultrasound therapy medical device for the treatment of calcific Aortic Stenosis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B2C
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cardiawave Comparables
Compare Cardiawave with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pi-Cardia | 78% | |
| AorticLab S.r.l. | 76% | |
| Johnson & Johnson | 67% |
Cardiawave Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Jun 30, 2026 | ||||
| Series B | Oct 1, 2020 | ||||
| Series A | Sep 27, 2018 | ||||
| Grant | Jun 15, 2018 | ||||
| Seed | Mar 1, 2017 | ||||
Seed | Dec 31, 2015 |
Key People
Founding team and executive leadership
Cardiawave Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Institut national de la santé et de la recherche médicale | Seed |
| Les Business Angels des Grandes Écoles | Series A |
| Centre National de la Recherche Scientifique | Seed |
| Agence Nationale de la Recherche | Series B |
| Business Angels des Grandes Ecoles | Seed |
| Angels'Bay Invest | Seed, Series A |
| Paris Business Angels | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2026
Open roles increased to 8, 2.7x the trailing average.
- Sep 7, 2026
Open roles increased to 6, 2.6x the trailing average.
Cardiawave Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cardiawave's valuation, stock price, and market status.
Is Cardiawave a public or private company?
Cardiawave is a private company.
What is the current stock price of Cardiawave?
Cardiawave is a private company, so its shares have no public market price. Caplight tracks Cardiawave's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cardiawave worth (valuation)?
Cardiawave's valuation is estimated at $27.2M based on funding round data.
Can I buy Cardiawave stock?
Cardiawave shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cardiawave's last funding round?
Cardiawave's most recent funding round was Crowdfunding on June 30, 2026.
Who are the main investors in Cardiawave?
Key investors in Cardiawave include Sofimac Innovation.
Will Cardiawave IPO soon?
No public IPO plans have been announced for Cardiawave.
How can I track Cardiawave secondary market activity?
Caplight tracks bids, offers, and trades in Cardiawave's shares on secondary markets.